Correlation Between Neximmune and Larimar Therapeutics
Can any of the company-specific risk be diversified away by investing in both Neximmune and Larimar Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neximmune and Larimar Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neximmune and Larimar Therapeutics, you can compare the effects of market volatilities on Neximmune and Larimar Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neximmune with a short position of Larimar Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neximmune and Larimar Therapeutics.
Diversification Opportunities for Neximmune and Larimar Therapeutics
0.63 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Neximmune and Larimar is 0.63. Overlapping area represents the amount of risk that can be diversified away by holding Neximmune and Larimar Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Larimar Therapeutics and Neximmune is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neximmune are associated (or correlated) with Larimar Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Larimar Therapeutics has no effect on the direction of Neximmune i.e., Neximmune and Larimar Therapeutics go up and down completely randomly.
Pair Corralation between Neximmune and Larimar Therapeutics
Given the investment horizon of 90 days Neximmune is expected to generate 1.05 times less return on investment than Larimar Therapeutics. In addition to that, Neximmune is 2.71 times more volatile than Larimar Therapeutics. It trades about 0.02 of its total potential returns per unit of risk. Larimar Therapeutics is currently generating about 0.06 per unit of volatility. If you would invest 330.00 in Larimar Therapeutics on July 21, 2024 and sell it today you would earn a total of 446.00 from holding Larimar Therapeutics or generate 135.15% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 86.49% |
Values | Daily Returns |
Neximmune vs. Larimar Therapeutics
Performance |
Timeline |
Neximmune |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Larimar Therapeutics |
Neximmune and Larimar Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Neximmune and Larimar Therapeutics
The main advantage of trading using opposite Neximmune and Larimar Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neximmune position performs unexpectedly, Larimar Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Larimar Therapeutics will offset losses from the drop in Larimar Therapeutics' long position.Neximmune vs. ZyVersa Therapeutics | Neximmune vs. Palisade Bio | Neximmune vs. Unicycive Therapeutics | Neximmune vs. Immix Biopharma |
Larimar Therapeutics vs. KBC Groep NV | Larimar Therapeutics vs. Pfizer Inc | Larimar Therapeutics vs. JPMorgan Chase Co | Larimar Therapeutics vs. Davis Select Worldwide |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Complementary Tools
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |